Plexera, JPT Sign Distribution, Proteomics Application Development Agreement | GenomeWeb

NEW YORK (GenomeWeb) – Plexera Biotechnology and JPT Peptide Technologies today announced a deal to distribute JPT's peptide-based products and services in China and to develop peptide-based applications on Plexera's PlexArray HT platform for high-throughput proteomics screening. 

Plexera will distribute JPT's products and services to the Chinese proteomics, immunotherapy, and vaccine markets, the companies said. Financial and other terms of the agreement were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.